Charles Schwab
MTEM

Charles Schwab’s Molecular Templates, Inc. MTEM Stock Holding History

Charles Schwab’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,733
Closed -$349K – 3687
2022
Q1 		$349K Buy
6,733
+494
+8% +$21.8K ﹤0.01% 3177
2021
Q4 		$367K Hold
6,239
– – ﹤0.01% 3244
2021
Q3 		$628K Sell
6,239
-11,800
-65% -$1.22M ﹤0.01% 3062
2021
Q2 		$2.12M Buy
18,039
+1,743
+11% +$228K ﹤0.01% 2698
2021
Q1 		$3.08M Buy
16,296
+1,769
+12% +$310K ﹤0.01% 2530
2020
Q4 		$2.05M Sell
14,527
-72
-0.5% -$10.6K ﹤0.01% 2585
2020
Q3 		$2.39M Buy
14,599
+10,556
+261% +$1.88M ﹤0.01% 2433
2020
Q2 		$837K Buy
4,043
+618
+18% +$144K ﹤0.01% 2678
2020
Q1 		$683K Buy
3,425
+377
+12% +$82.5K ﹤0.01% 2598
2019
Q4 		$640K Buy
3,048
+129
+4% +$18.5K ﹤0.01% 2730
2019
Q3 		$289K Hold
2,919
– – ﹤0.01% 2974
2019
Q2 		$366K Buy
2,919
+658
+29% +$71.5K ﹤0.01% 2954
2019
Q1 		$198K Buy
2,261
+559
+33% +$41K ﹤0.01% 3023
2018
Q4 		$104K Buy
1,702
+575
+51% +$40.1K ﹤0.01% 3087
2018
Q3 		$92K Hold
1,127
– – ﹤0.01% 3117
2018
Q2 		$89K Buy
+1,127
New +$128K ﹤0.01% 3101
2016
Q2 		– Sell
-538
Closed -$41K – 3149
2016
Q1 		$41K Hold
538
– – ﹤0.01% 3033
2015
Q4 		$43K Hold
538
– – ﹤0.01% 3077
2015
Q3 		$362K Hold
538
– – ﹤0.01% 2749
2015
Q2 		$359K Hold
538
– – ﹤0.01% 2801
2015
Q1 		$361K Hold
538
– – ﹤0.01% 2760
2014
Q4 		$283K Sell
538
-1,278
-70% -$639K ﹤0.01% 2867
2014
Q3 		$1.08M Sell
1,816
-2,332
-56% -$1.61M ﹤0.01% 2259
2014
Q2 		$2.71M Sell
4,148
-576
-12% -$382K ﹤0.01% 1815
2014
Q1 		$3.71M Buy
4,724
+764
+19% +$620K 0.01% 1564
2013
Q4 		$3.05M Buy
3,960
+475
+14% +$358K 0.01% 1645
2013
Q3 		$2.79M Buy
3,485
+2,245
+181% +$1.84M 0.01% 1631
2013
Q2 		$1.11M Buy
+1,240
New +$1.05M ﹤0.01% 2104

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab's MTEM Position: Q2 2022 in Review

Charles Schwab sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 6,733 shares — an estimated $349K sold.

Charles Schwab first reported a position in MTEM in Q2 2013 and held it in 28 quarters. The position peaked at $3.71M in Q1 2014. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Charles Schwab reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Charles Schwab sold 6,733 Molecular Templates, Inc. shares in Q2 2022, an estimated $349K.
  • Charles Schwab first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 28 quarters.
  • Charles Schwab's Molecular Templates, Inc. position peaked at $3.71M in Q1 2014.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.